PRLog - March 25, 2015 - WASHINGTON -- AstraZeneca will enter into a five-year research collaboration with the Harvard Stem Cell Institute in order to acclimatize a technique for the creation of human beta cells from stem cells for use in screens of AstraZeneca' s compound library to explore potential diabetes treatment options. In type 1 diabetes patients have to inject themselves with insulin to maintain blood glucose levels as beta cells are destroyed by an autoimmune response and in type 2 diabetes, beta cells either decrease or fail to function properly.
http://ift.tt/18Y2RlC
http://ift.tt/18Y2RlC
No comments:
Post a Comment